$1.18 Billion Inhaled Nitric Oxide Market by Application, Acute Respiratory Distress Syndrome - Global Opportunity Analysis and Industry Forecast, 2020-2027 - ResearchAndMarkets.com
The "Inhaled Nitric Oxide Market by Application, Acute Respiratory Distress Syndrome and Others: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
- The "Inhaled Nitric Oxide Market by Application, Acute Respiratory Distress Syndrome and Others: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
- The global inhaled nitric oxide market was valued at $634.4 million in 2019 and is estimated to reach $1,180.98 million by 2027, registering a CAGR of 8.1% from 2020-2027.
- Nitric oxide (iNO) is selective pulmonary vasodilation and is delivered to the patient via mechanical ventilation after dilution with an oxygen/air mixture nitric oxide delivery system.
- However, a The rise in the number of patients with chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) boost the growth of the inhaled nitric oxide market.